Supportive Care and Monitoring for Delirium-Related Complications
Objective
Recommend supportive care measures and monitoring strategies to prevent and manage complications associated with ICU delirium and its treatment.
Learning Points
- Apply lung‐protective ventilation and sedation‐minimization strategies to reduce delirium risk.
- Implement prophylaxis for VTE, stress ulcers, and ICU‐acquired infections.
- Recognize and manage iatrogenic toxicities: QT prolongation, extrapyramidal symptoms, and hemodynamic effects.
- Conduct multidisciplinary goals‐of‐care discussions aligned with patient values and prognosis.
1. Rationale for Supportive Care
Delirium is a manifestation of acute brain dysfunction that can perpetuate secondary organ injury, prolong the duration of mechanical ventilation, and increase the length of stay in the intensive care unit (ICU). An integrated approach to supportive care, encompassing ventilator management, sedation protocols, and prophylactic bundles, is crucial to mitigate the physiologic stressors that trigger or exacerbate delirium.
Delirium is associated with systemic inflammation and profound neurotransmitter imbalances. This state is often worsened by deep sedation and immobilization, which further impair cognitive function. The implementation of evidence-based bundles, such as the ABCDEF or PADIS bundles, unifies the management of pain, agitation, delirium, mobility, and sleep. This comprehensive strategy has been shown to shorten the duration of delirium and improve overall patient outcomes.
Clinical Pearl: Impact of Bundled Care
Early and consistent adoption of combined supportive-care bundles can reduce the incidence of delirium by up to 30% and significantly decrease the ICU length of stay. This highlights the synergistic benefit of addressing multiple risk factors simultaneously.
2. Mechanical Ventilation Strategies
Optimizing ventilator settings and implementing structured weaning protocols are fundamental to minimizing sedative exposure and ventilator-associated stress, thereby reducing the risk and severity of delirium.
2.1 Lung-Protective Ventilation
Adherence to lung-protective ventilation principles is key. This involves:
- Low Tidal Volume: Targeting 6 mL/kg of predicted body weight.
- Plateau Pressure Control: Maintaining a plateau pressure of ≤ 30 cm H₂O.
This approach attenuates biotrauma, reduces systemic cytokine release, and helps preserve the integrity of the blood–brain barrier, all of which are implicated in the pathophysiology of delirium.
2.2 Spontaneous Breathing Trials (SBT)
Daily spontaneous breathing trials are essential to assess a patient’s readiness for extubation. Key criteria for a successful trial include a respiratory rate < 35 breaths/min, SpO₂ ≥ 90%, and stable hemodynamics. Performing daily SBTs reduces total ventilator days and, consequently, the cumulative dose of sedatives required.
2.3 Sedation Targets
The goal is to maintain a light level of sedation, corresponding to a Richmond Agitation-Sedation Scale (RASS) score of −2 to 0. This level of sedation permits neurologic assessment, facilitates patient interaction, and enables early mobilization. Deep sedation (RASS ≤ −3) should be avoided as it is a major risk factor for delirium, particularly when benzodiazepines are used.
Case Vignette
A 72-year-old with pneumonia on volume-controlled ventilation at 8 mL/kg develops new confusion and agitation. After reducing the tidal volume to 6 mL/kg and lightening sedation to a target RASS of −1, the signs of delirium abate within 24 hours, and the patient successfully passes a spontaneous breathing trial.
3. Sedation Interruption and Protocolized Sedation
Systematic approaches like daily sedation interruption (DSI) and nurse-driven protocols help standardize sedation to the minimum effective dose. These strategies have been proven to shorten ventilation duration and lower delirium rates.
3.1 Daily Sedation Interruption (DSI)
Also known as a spontaneous awakening trial (SAT), DSI involves pausing continuous sedative infusions each morning while the patient is closely monitored. This “sedation vacation” allows clinicians to assess the patient’s underlying level of consciousness, evaluate pain control, and determine readiness for extubation.
3.2 Nurse-Driven Sedation Protocols
These protocols empower bedside nursing staff to titrate sedative agents like propofol or dexmedetomidine to a specified RASS target (typically −2 to 0) using a validated algorithm. This facilitates real-time adjustments based on patient needs, preventing over-sedation.
4. Prevention of ICU-Acquired Complications
Prophylactic measures targeting common ICU complications are essential, as each additional physiologic insult can contribute to or worsen delirium.
4.1 Venous Thromboembolism (VTE) Prophylaxis
- Pharmacologic: Low-molecular-weight heparin (e.g., enoxaparin 40 mg SC daily) or unfractionated heparin (5,000 units SC q8–12h) is standard unless a high risk of active bleeding exists.
- Mechanical: Intermittent pneumatic compression devices are used when anticoagulation is contraindicated.
4.2 Stress Ulcer Prophylaxis (SUP)
- Indications: Generally reserved for patients with high-risk features, such as mechanical ventilation for >48 hours or coagulopathy.
- Agents: Proton pump inhibitors (e.g., pantoprazole 40 mg IV daily) or H₂-receptor antagonists are commonly used. The choice should balance efficacy against risks like Clostridioides difficile infection and drug interactions.
4.3 Infection Control Bundles
- CLABSI Prevention: Adherence to maximal barrier precautions during insertion, chlorhexidine skin antisepsis, and daily review of line necessity are critical.
- VAP Prevention: Key measures include elevating the head of the bed to 30–45 degrees, regular oral care with chlorhexidine, and using endotracheal tubes with subglottic suctioning capabilities.
Clinical Pearl: Mobility and Circadian Rhythm
Integrating early mobilization and physical therapy with standard prophylaxis bundles provides a powerful, non-pharmacologic intervention. Mobility helps restore normal sleep-wake cycles (circadian rhythm), reduces delirium severity, and improves long-term physical function.
5. Management of Iatrogenic Drug Toxicities
Pharmacologic agents used to manage agitation or sedation can precipitate significant adverse events. Proactive monitoring and prompt management are essential to ensure patient safety.
| Adverse Event | Mechanism & Risk Factors | Monitoring | Action Thresholds & Management |
|---|---|---|---|
| QTc Prolongation | hERG K⁺ channel blockade. Risks: female sex, hypokalemia, hypomagnesemia, concurrent QT-prolonging drugs. | Baseline ECG, then daily for 3 days. If QTc remains < 480 ms, monitor q48h. | QTc > 500 ms or ΔQTc > 60 ms: Reduce dose (e.g., haloperidol ↓ 50%), correct electrolytes, switch to lower-risk agent (e.g., olanzapine). |
| Extrapyramidal Symptoms (EPS) | Dopamine D₂ receptor blockade. Presents as acute dystonia, akathisia, or parkinsonism. | Daily clinical assessment for new-onset rigidity, restlessness, or involuntary movements. | Dystonia: Benztropine 1–2 mg IV or diphenhydramine 25 mg IV. Akathisia: Beta-blockers (e.g., propranolol) or benzodiazepines. |
| Dexmedetomidine Hemodynamics | Central α₂-agonist activity. Can cause significant bradycardia and hypotension. | Continuous heart rate (HR) and mean arterial pressure (MAP) monitoring. | Start low (0.2 µg/kg/h) and titrate slowly. Maintain euvolemia to mitigate hypotension. Reduce or stop infusion for severe bradycardia or hypotension. |
6. Multidisciplinary Goals of Care Conversations
Persistent delirium, especially in the context of ongoing invasive support, necessitates clear communication and shared decision-making that aligns with the patient’s values and prognosis.
6.1 Decision Points for Invasive Therapies
When delirium persists for more than 7 days, it serves as a critical trigger to reassess the goals of care. This includes re-evaluating the appropriateness of continued mechanical ventilation, renal replacement therapy, and vasopressor support, weighing the burdens of treatment against the likelihood of a meaningful recovery.
6.2 Family Engagement
Engaging families is paramount. Structured communication tools and proactive palliative care consultations can facilitate these difficult conversations. The VALUE mnemonic is a useful guide for clinicians:
- Value family statements
- Acknowledge emotions
- Listen
- Understand the patient as a person
- Elicit questions
6.3 Ethical and Prognostic Considerations
The principle of proportionality should guide decisions. Interventions may be ethically withdrawn or limited when their burden outweighs the potential benefit, or when the likelihood of the patient achieving a quality of life they would find acceptable is low.
Case Vignette
A 68-year-old patient has persistent delirium for 10 days while on a ventilator. A family meeting, guided by a palliative care specialist, reveals the patient’s previously expressed wishes to avoid prolonged mechanical life support. The goals of care are shifted towards comfort, and the ventilator weaning plan is adjusted accordingly.
7. Documentation and Handoff Integration
Consistent and clear documentation of delirium status, sedation targets, and supportive care measures is vital for ensuring patient safety, continuity of care, and adherence to protocols across shifts.
- Delirium Screening: Document the CAM-ICU or ICDSC score every nursing shift to track trends.
- Sedation Management: Record the target RASS, outcomes of sedation holds (SATs), and any adjustments to sedative infusions.
- Structured Handoff: Use a standardized tool like SBAR for transitions of care:
- Situation: Current delirium status (e.g., “CAM-ICU positive, hyperactive”).
- Background: Key medications, active protocols, recent events.
- Assessment: Current sedation depth, recent ECG results, mobility status.
- Recommendations: Plan for the next shift (e.g., “Continue RASS target -1 to 0, attempt SAT in AM”).
- Pharmacist Role: Clinical pharmacists can create and maintain templates that highlight a patient’s delirium risk factors, current prophylaxis regimen, and any pending goals-of-care discussions.
Clinical Pearl: The Power of Checklists
Embedding electronic checklists for the ABCDEF bundle and other supportive care elements directly into the electronic health record (EHR) and ICU daily workflow significantly reduces omissions and standardizes the delivery of care, leading to better compliance and improved patient outcomes.
References
- Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306.
- Devlin JW, Skrobik Y, Gélinas C, et al. Clinical Practice Guideline for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018;46(9):e825–e873.
- Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286(21):2703–2710.
- Girard TD, Exline MC, Carson SS, et al. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness. N Engl J Med. 2018;379(26):2506–2516.
- Inouye SK, Bogardus ST Jr, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999;340(9):669–676.
- van den Boogaard M, Pickkers P, Slooter AJ, et al. Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICu patients) delirium prediction model for intensive care patients: observational multicentre study. BMJ. 2012;344:e420.
- Hshieh TT, Yue J, Oh E, et al. Effectiveness of multicomponent nonpharmacological delirium interventions: a meta-analysis. JAMA Intern Med. 2015;175(4):512–520.
- Shehabi Y, Bellomo R, Kadiman S, et al. Effect of Prax- and Non-Prax-Oriented Sedation on Delirium in Mechanically Ventilated, Critically Ill Adults: A Randomized Clinical Trial. Crit Care Med. 2018;46(6):850–859.
- Al‐Aama T, Brymer C, Gutmanis I, et al. The prediction, diagnosis and management of delirium in the elderly: a review. Int J Geriatr Psychiatry. 2011;26(7):687–694.
- Hatta K, Kishi Y, Wada K, et al. Antipsychotics for delirium in the elderly. JAMA Psychiatry. 2014;71(4):397–403.
- Bourne RS, Mills GH, Minelli C. A comparison of the effect of sedation on the duration of mechanical ventilation in critically ill patients. Crit Care. 2008;12(2):R52.
- Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291(14):1753–1762.
- Neufeld KJ, Yue J, Robinson TN, et al. Antipsychotic Medication for Prevention and Treatment of Delirium in Hospitalized Adults: A Systematic Review and Meta-Analysis. J Am Geriatr Soc. 2016;64(4):705–714.
- Ray WA, Chung CP, Murray KT, et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360(1):225–235.
- Balas MC, Weinhouse GL, Denehy L, et al. Interpreting and Implementing the 2018 Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption Clinical Practice Guideline. Crit Care Med. 2018;46(9):1464–1470.
- Ely EW. The ABCDEF Bundle: Science and Philosophy of How ICU Liberation Serves Patients and Families. Crit Care Med. 2017;45(2):321–330.
- Morandi A, Piva S, Ely EW, et al. Worldwide Survey of the “Assessing Pain, Both Spontaneous Awakening and Breathing Trials, Choice of Drugs, Delirium Monitoring/Management, Early Exercise/Mobility, and Family Empowerment” (ABCDEF) Bundle. Crit Care Med. 2017;45(11):e1111–e1122.
- Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008;371(9607):126–134.
